Aehr Test Systems
AEHR · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.65 | 0.08 | 1.43 | -0.04 |
| FCF Yield | -4.39% | 0.30% | 0.94% | 0.50% |
| EV / EBITDA | -296.57 | 20.89 | 59.32 | 19.04 |
| Quality | ||||
| ROIC | -2.92% | 22.76% | 16.25% | 14.83% |
| Gross Margin | 40.59% | 49.15% | 50.41% | 46.56% |
| Cash Conversion Ratio | 1.89 | 0.05 | 0.69 | 0.16 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.17% | 9.22% | 57.58% | 31.62% |
| Free Cash Flow Growth | -1,330.59% | -88.36% | 692.03% | 137.30% |
| Safety | ||||
| Net Debt / EBITDA | 15.95 | -3.11 | -1.58 | -3.09 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.83 | 0.90 | 1.35 | 1.80 |
| Cash Conversion Cycle | 477.56 | 403.44 | 259.81 | 238.21 |